Posts

Showing posts with the label demerol

Meperidine (Demerol) Is Approved By Food and Drug Administration for Treatment of Moderate-To-Severe Pain

Image
  Meperidine Meperidine (demerol) (C15H21NO2·HCl (Pethidin·Hydrochlorid)) belongs to the class of opioid analgesics, which work by relieving the body from the actions of certain chemicals called opioids. It works by changing the way the brain and nervous system respond to pain. Meperidine, also known as Pethidine, and sold under the brand name Demerol is recommended for the quick relief of moderate to severe pain, which is delivered either as an intravenous, intramuscular, or oral injection. In the U.S., the drug has also been approved by the FDA (Food and Drug Administration) for the treatment of moderate-to-severe pain. Meperidine is controlled under Schedule II of the Controlled Substances Act. It was earlier prescribed as opioid analgesic and now used only for the prevention and treatment of postoperative shivering, drug-induced rigors. Besides its antinociceptive, anti-inflammatory, and analgesic properties, there are other reported medical uses for Meperidine (demerol). It is

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides